GoodRx Holdings, Inc.

GDRX

US38246G1085

Internet Services

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-17 EDT			5-day change	1st Jan Change
7.48 ^USD	-7.20%		+13.33%	+11.64%

05-17	UBS Adjusts Price Target on GoodRx Holdings to $9 From $8, Maintains Neutral Rating	MT
05-17	Deutsche Bank Adjusts GoodRx Price Target to $9 From $8, Maintains Hold Rating	MT

GoodRx Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024

May 09, 2024 at 06:05 am

GoodRx Holdings, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 197.88 million compared to USD 183.99 million a year ago. Net loss was USD 1.01 million compared to USD 3.29 million a year ago.

Latest news about GoodRx Holdings, Inc.

UBS Adjusts Price Target on GoodRx Holdings to $9 From $8, Maintains Neutral Rating	05-17	MT
Deutsche Bank Adjusts GoodRx Price Target to $9 From $8, Maintains Hold Rating	05-17	MT
North American Morning Briefing : The "Everything -2-	05-17	DJ
GoodRx Shares Rise After Raymond James Upgrade	05-16	MT
Raymond James Upgrades GoodRx Holdings to Outperform From Market Perform	05-16	MT
Sector Update: Health Care Stocks Advance in Afternoon Trading	05-15	MT
GoodRx Signs Direct Contracting Agreement With Kroger; GoodRx Shares Rise	05-15	MT
Sector Update: Health Care Stocks Rise Pre-Bell Wednesday	05-15	MT
GoodRx Signs Direct Contracting Agreement With Kroger	05-15	MT
GoodRx and Kroger Sign Direct Contracting Agreement	05-15	CI
Deutsche Bank Adjusts GoodRx Price Target to $8 From $9, Maintains Hold Rating	05-13	MT
Transcript : GoodRx Holdings, Inc., Q1 2024 Earnings Call, May 09, 2024	05-09
GoodRx Holdings' Q1 Adjusted Earnings, Revenue Rise	05-09	MT
Earnings Flash (GDRX) GOODRX HOLDINGS Reports Q1 Adjusted EPS $0.08	05-09	MT
Earnings Flash (GDRX) GOODRX HOLDINGS Reports Q1 Revenue $197.9M	05-09	MT
GoodRx Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09	CI
GoodRx Holdings, Inc. Provides Earnings Guidance for the Second Quarter and Full Year 2024	05-09	CI
North American Morning Briefing : Stock Futures -2-	04-11	DJ
KeyBanc Upgrades GoodRx to Overweight From Sector Weight on Increased Conviction Around Monthly Active Customers, Sets $9 Price Target	04-10	MT
North American Morning Briefing : Traders Await -2-	04-10	DJ
North American Morning Briefing : Markets Steady -2-	03-26	DJ
GoodRx Shares Jump Following Wells Fargo Upgrade, Price Target Boost	03-25	MT
Top Premarket Gainers	03-25	MT
Wells Fargo Upgrades GoodRx Holdings to Overweight From Equalweight, Adjusts Price Target to $10 From $7.50	03-25	MT
Transcript : GoodRx Holdings, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-14-2024 09:00 AM	03-14

Chart GoodRx Holdings, Inc.

Duration

Period

More charts

Company Profile

GoodRx Holdings, Inc. provides a consumer-focused digital healthcare platform in the United States. It offer consumers free access to transparent and lower prices for generic and brand medications, as well as comprehensive healthcare research and information. It also equips healthcare professionals to find and prescribe affordable medications. It offers information and tools to help consumers compare prices and save on their prescription drug purchases. It operates a price comparison platform that provides consumers with geographically relevant prescription pricing and provides access to negotiated prices through its codes that can be used to save money on prescriptions across the United States (the prescription transactions offering). It also offers other healthcare products and services, including pharmaceutical manufacturer solutions, subscriptions, and telehealth services. Its subscription offerings provide additional benefits to consumers of its prescription transactions offering.

Sector

Internet Services

Calendar

2024-06-06 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for GoodRx Holdings, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

7.48 USD

Average target price

9.292 USD

Spread / Average Target

+24.22%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Internet Services

	1st Jan change	Capi.
GOODRX HOLDINGS, INC.	+11.64%	2.81B
TENCENT HOLDINGS LIMITED	+34.54%	470B
NETFLIX, INC.	+27.57%	268B
UBER TECHNOLOGIES, INC.	+6.66%	137B
PROSUS N.V.	+31.41%	96.16B
AIRBNB, INC.	+6.99%	92.47B
SPOTIFY TECHNOLOGY S.A.	+61.15%	60.06B
DOORDASH, INC.	+18.75%	48.02B
NASPERS LIMITED	+24.94%	37.9B
COSTAR GROUP, INC.	+0.13%	35.73B

Other Internet Services